Lee C Y, Pellikka P A, McCully R B, Mahoney D W, Seward J B
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.
J Am Coll Cardiol. 1999 Feb;33(2):506-11. doi: 10.1016/s0735-1097(98)00599-3.
To compare transesophageal atrial pacing stress echocardiography with dobutamine stress echocardiography for feasibility, safety, duration, patient acceptance and concordance in inducing wall motion abnormalities.
Transesophageal atrial pacing is an effective method of increasing heart rate and has been used in the assessment of coronary artery disease.
Both tests were performed in sequence on the same patients in random order. Transesophageal atrial pacing stress echocardiography began at a heart rate of 10 beats/min above the baseline value and was increased by 20 beats/min every two min until 85% of the age-predicted maximum heart rate or another end point was reached. Dobutamine echocardiography was performed using three-min stages and a maximum dose of 40 microg/kg per min. Atropine (total dose < or =2 mg) was administered at the start of the 40 microg/kg per min stage if needed to augment heart rate or during pacing if Wenckebach heart block occurred.
Transesophageal atrial pacing stress echocardiography was feasible in 100 of 104 patients (96%); the duration (8.6+/-3.6 min) was significantly shorter than that of dobutamine stress echocardiography (15.1+/-3.9 min) (p = 0.0001). With transesophageal atrial pacing stress echocardiography, the recovery period was shorter, symptoms and dysrhythmias were fewer, hypertension and hypotension were less common and target heart rate was more frequently achieved. No complications occurred with either test. Patient acceptance was satisfactory. Agreement between results of both tests was good for segmental wall motion scoring with a 16-segment model, scores 1 to 5 (kappa: rest, 0.79; peak, 0.57) and test interpretation (normal, ischemia, infarction or resting wall motion abnormality with ischemia) (kappa: 0.77).
Transesophageal atrial pacing stress echocardiography is a feasible, well-tolerated alternative to dobutamine stress echocardiography. It can be performed rapidly and shows good agreement with dobutamine stress echocardiography in the induction of myocardial ischemia.
比较经食管心房起搏负荷超声心动图与多巴酚丁胺负荷超声心动图在诱导室壁运动异常方面的可行性、安全性、检查持续时间、患者接受度及一致性。
经食管心房起搏是增加心率的一种有效方法,已用于冠状动脉疾病的评估。
两项检查按随机顺序在同一患者身上依次进行。经食管心房起搏负荷超声心动图从高于基线值10次/分钟的心率开始,每两分钟增加20次/分钟,直至达到年龄预测最大心率的85%或其他终点。多巴酚丁胺超声心动图采用三分钟阶段给药,最大剂量为每分钟40μg/kg。如果需要增加心率,在每分钟40μg/kg阶段开始时给予阿托品(总剂量≤2mg),或在起搏过程中出现文氏房室传导阻滞时给予。
104例患者中有100例(96%)经食管心房起搏负荷超声心动图检查可行;其持续时间(8.6±3.6分钟)明显短于多巴酚丁胺负荷超声心动图(15.1±3.9分钟)(p = 0.0001)。经食管心房起搏负荷超声心动图检查后恢复期更短,症状和心律失常更少,高血压和低血压更少见,更常能达到目标心率。两种检查均未发生并发症。患者接受度良好。两种检查结果在使用16节段模型进行节段性室壁运动评分(评分1至5)方面一致性良好(kappa值:静息时为0.79;峰值时为)0.57),在检查结果解读(正常、缺血、梗死或伴有缺血的静息室壁运动异常)方面一致性也良好(kappa值:0.77)。
经食管心房起搏负荷超声心动图是一种可行的、耐受性良好的替代多巴酚丁胺负荷超声心动图的方法。它检查速度快,在诱导心肌缺血方面与多巴酚丁胺负荷超声心动图一致性良好。